GE gets behind Cerapedics and its i-FACTOR bone graft

Colorado-based Cerapedics closes $9 million in venture debt financing from GE Capital's Health Financial Services in support of the i-FACTOR Peptide Enhanced Bone Graft. Tech and healthcare giant GE (NYSE:GE) put some skin in Cerapedics and its i-FACTOR bone graft, funding a $9 million venture debt financing round for the Colorado-based company. Cerapedics Inc., GE HealthcareNews Well, Funding Roundup, Orthobiologics, Resorbable bone materialsread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news